Atlas Trials

Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)

Clinical trial NCT05116579 · RECRUITING

Trial details

NCT number
NCT05116579
Sponsor
Sun Yat-sen University
Status
RECRUITING
Study type
OBSERVATIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2021-10-31
Primary completion
2023-03-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.